Cargando…

Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems Studies

Global repositories of postmarketing safety reports improve understanding of real-life drug toxicities, often not observed in clinical trials. The aim of this scoping review was to map the evidence from spontaneous reporting systems studies (SRSs) of antiangiogenic drugs (AADs) in cancer patients an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciccone, Valerio, Ziche, Marina, Spini, Andrea, Donnini, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302288/ https://www.ncbi.nlm.nih.gov/pubmed/37375814 http://dx.doi.org/10.3390/ph16060867

Ejemplares similares

Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis
por: Spini, Andrea, et al.
Publicado: (2022)

How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance
por: Ciccone, Valerio, et al.
Publicado: (2020)

Repurposing of drugs for triple negative breast cancer: an overview
por: Spini, Andrea, et al.
Publicado: (2020)

Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
por: Ciccone, Valerio, et al.
Publicado: (2018)

Correction to: Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
por: Ciccone, Valerio, et al.
Publicado: (2019)

Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
por: Morbidelli, L, et al.
Publicado: (2003)

ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL-8/Notch signaling cascade
por: Ciccone, Valerio, et al.
Publicado: (2022)

New Insights Into Blood-Brain Barrier Maintenance: The Homeostatic Role of β-Amyloid Precursor Protein in Cerebral Vasculature
por: Ristori, Emma, et al.
Publicado: (2020)

ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 Output
por: Terzuoli, Erika, et al.
Publicado: (2019)

Scoping Review on Platelets and Tumor Angiogenesis: Do We Need More Evidence or Better Analysis?
por: Filippelli, Arianna, et al.
Publicado: (2022)

Real-World Utilization of Target- and Immunotherapies for Lung Cancer: A Scoping Review of Studies Based on Routinely Collected Electronic Healthcare Data
por: Spini, Andrea, et al.
Publicado: (2021)

Sex differences in the utilization of drugs for COVID‐19 treatment among elderly residents in a sample of Italian nursing homes
por: Spini, Andrea, et al.
Publicado: (2022)

Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents
por: Morbidelli, Lucia, et al.
Publicado: (2016)

Development and validation of a case-finding algorithm for the identification of non-small cell lung cancers in a region-wide Italian pathology registry
por: Spini, Andrea, et al.
Publicado: (2022)

Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications
por: Bartolini, Claudia, et al.
Publicado: (2023)

Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing
por: Nannelli, Ginevra, et al.
Publicado: (2020)

Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data
por: Roberto, Giuseppe, et al.
Publicado: (2020)

PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells
por: Bazzani, Lorenzo, et al.
Publicado: (2018)

PGE(2)/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells
por: Bazzani, Lorenzo, et al.
Publicado: (2017)

Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer
por: Fuloria, Jyotsna
Publicado: (2012)

Monitoring Endothelial and Tissue Responses to Cobalt Ferrite Nanoparticles and Hybrid Hydrogels
por: Finetti, Federica, et al.
Publicado: (2016)

Inhibition of cell cycle progression by the hydroxytyrosol–cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells
por: Terzuoli, Erika, et al.
Publicado: (2017)

Involvement of Bradykinin B2 Receptor in Pathological Vascularization in Oxygen-Induced Retinopathy in Mice and Rabbit Cornea
por: Terzuoli, Erika, et al.
Publicado: (2018)

Bradykinin B2 Receptor Contributes to Inflammatory Responses in Human Endothelial Cells by the Transactivation of the Fibroblast Growth Factor Receptor FGFR-1
por: Terzuoli, Erika, et al.
Publicado: (2018)

First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender Prospective
por: Spini, Andrea, et al.
Publicado: (2021)

Antiangiogenic drugs in ovarian cancer
por: Kumaran, G C, et al.
Publicado: (2009)

Potential of Induced Metabolic Bioluminescence Imaging to Uncover Metabolic Effects of Antiangiogenic Therapy in Tumors
por: Indraccolo, Stefano, et al.
Publicado: (2016)

Suppression of Autoimmune Retinal Inflammation by an Antiangiogenic Drug
por: Yoshimura, Takeru, et al.
Publicado: (2013)

Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety
por: Welker, Martin-Walter, et al.
Publicado: (2013)

Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical Studies
por: Tian, Hui, et al.
Publicado: (2021)

mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity
por: Finetti, Federica, et al.
Publicado: (2015)

Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and −186 expression: Novel mechanism of VEGF modulation in prostate cancer
por: Terzuoli, Erika, et al.
Publicado: (2016)

Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells
por: Ristori, Emma, et al.
Publicado: (2020)

Uncovering the gender health data gap
por: Lego, Vanessa di
Publicado: (2023)

Antagonism of Bradykinin B2 Receptor Prevents Inflammatory Responses in Human Endothelial Cells by Quenching the NF-kB Pathway Activation
por: Terzuoli, Erika, et al.
Publicado: (2014)

Risk profile for antiangiogenic agent-related osteonecrosis of the jaws
por: Caminha, Raquel D’Aquino Garcia, et al.
Publicado: (2019)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants.
por: Ziche, M., et al.
Publicado: (1998)

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
por: Ribatti, Domenico
Publicado: (2010)

The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression
por: Ciesielski, Oskar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_505582c1ck8l4jsu7bn5urjvi2